Its leading investigational drug demonstrated relatively high levels of weight loss in a late-stage clinical trial.

The company is widening its participation in a U.S. Navy program to update countermeasures for military aircraft.

SpaceX ( SPCX -0.11%) reported its third-quarter earnings on Oct. 20, and the results beat analyst expectations throughout ...

But if Anthropic attracts a lower valuation than expected for its upcoming IPO, it might not raise as much money as it ...

Amazon has multiple business lines, including fast-growing revenue streams from cloud and advertising services, but ...

Anthropic’s proposed $45 billion Nscale expansion could help fuel its growth, but it also adds another enormous bill ahead of ...

Having said all that, CoreWeave isn't exactly WeWork, and for several key reasons. Most importantly, it is where the revenue ...

This is reflected in Wall Street's outlook for the stock. Micron reported $75.52 in earnings per share during its fiscal 2026 ...

Marketing spend increases and AI-driven risk tools position Capital One to capture premium customers while synergies fuel ...

Throughout the initial public offering (IPO) process, Space Exploration Technologies ignored convention. Now, everyday ...

Automation is decoupling earnings growth from economic headwinds, letting Neptune expand without adding staff.

Financially, Braze has more than $300 million in net cash on its balance sheet, while operating margin has been improving ...